Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer S (Q46966646)
Jump to navigation
Jump to search
scientific article published in March 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer S |
scientific article published in March 2006 |
Statements
1 reference
Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer S (English)
1 reference
Andreas du Bois
1 reference
Beatrice Weber
1 reference
Justine Rochon
1 reference
Werner Meier
1 reference
Alain Goupil
1 reference
Sigrid Olbricht
1 reference
Jean-Claude Barats
1 reference
Walther Kuhn
1 reference
Hubert Orfeuvre
1 reference
Uwe Wagner
1 reference
Barbara Richter
1 reference
Hans-Joachim Lueck
1 reference
Jacobus Pfisterer
1 reference
Serban Costa
1 reference
Willibald Schroeder
1 reference
Rainer Kimmig
1 reference
Eric Pujade-Lauraine
1 reference
Arbeitsgemeinschaft Gynaekologische Onkologie
1 reference
Ovarian Cancer Study Group
1 reference
Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens
1 reference
1 March 2006
1 reference
1 reference
24
1 reference
7
1 reference
1127-1135
1 reference
Identifiers
1 reference
1 reference